{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T03:29:42Z","timestamp":1768793382322,"version":"3.49.0"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771265"],"award-info":[{"award-number":["81771265"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2017208063"],"award-info":[{"award-number":["H2017208063"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.actbio.2019.06.059","type":"journal-article","created":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T17:55:49Z","timestamp":1564854949000},"page":"93-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Exploring the functions of polymers in adenovirus-mediated gene delivery: Evading immune response and redirecting tropism"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7186-3968","authenticated-orcid":false,"given":"Yanping","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqian","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingtian","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zibin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2019.06.059_b0005","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and problems with the use of viral vectors for gene therapy","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.actbio.2019.06.059_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2007.10.005","article-title":"Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications","volume":"132","author":"Hartman","year":"2008","journal-title":"Virus Res."},{"key":"10.1016\/j.actbio.2019.06.059_b0015","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3181\/00379727-84-20714","article-title":"Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissu1","volume":"84","author":"Rowe","year":"1953","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.actbio.2019.06.059_b0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF02789331","article-title":"Methods for construction of adenovirus vectors","volume":"3","author":"Graham","year":"1995","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.actbio.2019.06.059_b0025","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s11262-017-1488-1","article-title":"Oncolytic viruses: adenoviruses","volume":"53","author":"Niemann","year":"2017","journal-title":"Virus Genes"},{"key":"10.1016\/j.actbio.2019.06.059_b0030","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2174\/156800911796798896","article-title":"Current targeting strategies for adenovirus vectors in cancer gene therapy","volume":"11","author":"Yao","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.actbio.2019.06.059_b0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/2277-9175.98152","article-title":"Viral and nonviral delivery systems for gene delivery","volume":"1","author":"Nayerossadat","year":"2012","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.actbio.2019.06.059_b0040","first-page":"5201","article-title":"Imaging and antitumoral effect of a cyclo-oxygenase 2-specific replicative adenovirus for small metastatic gastric cancer lesions","volume":"35","author":"Kosaka","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.actbio.2019.06.059_b0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1142\/S1568558610000227","article-title":"Smart adenovirus nanocomplexes for systemic delivery","volume":"05","author":"Kang","year":"2010","journal-title":"Gene Ther. Regul."},{"key":"10.1016\/j.actbio.2019.06.059_b0050","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/43977","article-title":"Virus treatment questioned after gene therapy death","volume":"401","author":"Lehrman","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2019.06.059_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2011.00040","article-title":"Immune recognition of gene transfer vectors: focus on adenovirus as a paradigm","volume":"2","author":"Aldhamen","year":"2011","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2019.06.059_b0060","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/jcb.22328","article-title":"The influence of innate and pre-existing immunity on adenovirus therapy","volume":"108","author":"Zaiss","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.actbio.2019.06.059_b0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/hum.2014.001","article-title":"Innate immunity to adenovirus","volume":"25","author":"Hendrickx","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0070","doi-asserted-by":"crossref","first-page":"R328","DOI":"10.1016\/j.cub.2010.01.044","article-title":"Sensing and Signaling in Antiviral Innate Immunity","volume":"20","author":"O'Neill","year":"2010","journal-title":"Curr. Biol."},{"key":"10.1016\/j.actbio.2019.06.059_b0075","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/mt.2009.130","article-title":"New insights on adenovirus as vaccine vectors","volume":"17","author":"Lasaro","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0080","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1517\/14712590903307388","article-title":"Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors","volume":"9","author":"Seregin","year":"2009","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0085","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/JVI.01878-08","article-title":"Effect of neutralizing sera on factor X-mediated adenovirus serotype 5 gene transfer","volume":"83","author":"Parker","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.actbio.2019.06.059_b0090","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/infdis\/jiq161","article-title":"Effect of preexisting immunity to adenovirus on transgene product-specific genital T cell responses on vaccination of mice with a homologous vector","volume":"203","author":"Haut","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actbio.2019.06.059_b0095","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.4049\/jimmunol.174.11.7179","article-title":"Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein","volume":"174","author":"Sumida","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.actbio.2019.06.059_b0100","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.vaccine.2009.10.091","article-title":"Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive","volume":"28","author":"Hutnick","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.actbio.2019.06.059_b0105","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tips.2012.04.005","article-title":"Adenovirus receptors: implications for targeting of viral vectors","volume":"33","author":"Arnberg","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.actbio.2019.06.059_b0110","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1743-422X-7-148","article-title":"Integrin \u03b1v\u03b25 is a primary receptor for adenovirus in CAR-negative cells","volume":"7","author":"Lyle","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.actbio.2019.06.059_b0115","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.copbio.2010.06.011","article-title":"Adenovirus: a blueprint for non-viral gene delivery V Ann Chailertvanitkul and Colin W Pouton","volume":"21","author":"Va","year":"2010","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.actbio.2019.06.059_b0120","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/sj.cgt.7700928","article-title":"Transductional targeting of adenovirus vectors for gene therapy","volume":"13","author":"Glasgow","year":"2006","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0125","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/gt.2011.87","article-title":"Coagulation factor X mediates adenovirus type 5 liver gene transfer in non-human primates (Microcebus murinus)","volume":"19","author":"Alba","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0130","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1021\/mp8000974","article-title":"Scavenger receptor A: a new route for adenovirus 5","volume":"6","author":"Haisma","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2019.06.059_b0135","doi-asserted-by":"crossref","first-page":"9183","DOI":"10.1128\/JVI.77.17.9183-9191.2003","article-title":"Adenovirus type 11 uses CD46 as a cellular receptor","volume":"77","author":"Segerman","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.actbio.2019.06.059_b0140","doi-asserted-by":"crossref","first-page":"14429","DOI":"10.1128\/JVI.79.22.14429-14436.2005","article-title":"CD46 is a cellular receptor for All species B adenoviruses except types 3 and 7","volume":"79","author":"Marttila","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.actbio.2019.06.059_b0145","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/nm952","article-title":"CD46 is a cellular receptor for group B adenoviruses","volume":"9","author":"Gaggar","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2019.06.059_b0150","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nm.2270","article-title":"Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14","volume":"17","author":"Wang","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2019.06.059_b0155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nm.2267","article-title":"The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis","volume":"17","author":"Nilsson","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2019.06.059_b0160","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/pharmaceutics3030338","article-title":"Adenovirus vector-derived VA-RNA-mediated innate immune responses","volume":"3","author":"Machitani","year":"2011","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.actbio.2019.06.059_b0165","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/cas.13228","article-title":"Recent advances in genetic modification of adenovirus vectors for cancer treatment","volume":"108","author":"Yamamoto","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.actbio.2019.06.059_b0170","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1089\/hum.2004.15.1034","article-title":"Targeted adenovirus vectors","volume":"15","author":"Mizuguchi","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0175","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.3390\/v2092013","article-title":"Improving adenovirus based gene transfer: strategies to accomplish immune evasion","volume":"2","author":"Seregin","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.actbio.2019.06.059_b0180","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1517\/17425240802507636","article-title":"Cancer gene therapy with targeted adenoviruses","volume":"5","author":"Bachtarzi","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.actbio.2019.06.059_b0185","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1517\/17425247.2016.1158707","article-title":"Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy","volume":"13","author":"Yoon","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.actbio.2019.06.059_b0190","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/10430349950018021","article-title":"PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo","volume":"10","author":"O'Riordan","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0195","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1517\/14712590903187053","article-title":"Engineered adenovirus serotypes for overcoming anti-vector immunity","volume":"9","author":"Dharmapuri","year":"2009","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0200","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/anie.200461832","article-title":"Glycoviruses: chemical glycosylation retargets adenoviral gene transfer","volume":"44","author":"Pearce","year":"2005","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.actbio.2019.06.059_b0205","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.addr.2011.12.011","article-title":"Evolution of oncolytic adenovirus for cancer treatment","volume":"64","author":"Choi","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2019.06.059_b0210","first-page":"566","article-title":"Acute intravenous toxicity of dimethyl sulfoxide, polyethylene glycol 400, dimethylformamide, absolute ethanol, and benzyl alcohol in inbred mouse strains","volume":"44","author":"Montaguti","year":"1994","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.actbio.2019.06.059_b0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijpharm.2007.08.025","article-title":"Development of PEGylated adenovirus vector with targeting ligand","volume":"354","author":"Eto","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2019.06.059_b0220","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1128\/JVI.75.10.4792-4801.2001","article-title":"\u201cStealth\u201d adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung","volume":"75","author":"Croyle","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.actbio.2019.06.059_b0225","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1089\/10430340050111368","article-title":"Development of a rapid method for the PEGylation of adenoviruses with enhanced transduction and improved stability under harsh storage conditions","volume":"11","author":"Ma","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-2478(97)00049-7","article-title":"Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response","volume":"57","author":"Christ","year":"1997","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.actbio.2019.06.059_b0235","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/eji.1830270312","article-title":"Humoral immune response to the capsid components of recombinant adenoviruses: routes of immunization modulate virus-induced Ig subclass shifts","volume":"27","author":"Gah\u00e9ry-S\u00e9gard","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.actbio.2019.06.059_b0240","doi-asserted-by":"crossref","first-page":"6729","DOI":"10.1128\/JVI.73.8.6729-6742.1999","article-title":"Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs","volume":"73","author":"Harvey","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.actbio.2019.06.059_b0245","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1089\/104303402760372972","article-title":"PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver","volume":"13","author":"Croyle","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0250","doi-asserted-by":"crossref","first-page":"11804","DOI":"10.1021\/acs.analchem.6b03437","article-title":"Analysis of pre-existing IgG and IgM antibodies against polyethylene glycol (PEG) in the general population","volume":"88","author":"Yang","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.actbio.2019.06.059_b0255","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.jaci.2015.10.034","article-title":"Pre-existing anti\u2013polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer","volume":"137","author":"Ganson","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.actbio.2019.06.059_b0260","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.7150\/thno.22164","article-title":"Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes","volume":"8","author":"Hsieh","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.actbio.2019.06.059_b0265","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ymthe.2004.09.015","article-title":"Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses","volume":"11","author":"Mok","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0270","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1089\/hum.2005.16.1439","article-title":"Elimination of innate immune responses and liver inflammation by PEGylation of adenoviral vectors and methylprednisolone","volume":"16","author":"De Geest","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0275","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.gt.3302441","article-title":"PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile","volume":"12","author":"Croyle","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0280","doi-asserted-by":"crossref","first-page":"15021","DOI":"10.1038\/mto.2015.21","article-title":"Evaluation of polymer shielding for adenovirus serotype 6 (Ad6) for systemic virotherapy against human prostate cancers","volume":"3","author":"Nguyen","year":"2016","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.actbio.2019.06.059_b0285","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3390\/v2102290","article-title":"Tropism-modification strategies for targeted gene delivery using adenoviral vectors","volume":"2","author":"Coughlan","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.actbio.2019.06.059_b0290","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrmicro1927","article-title":"Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded","volume":"6","author":"Cattaneo","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.actbio.2019.06.059_b0295","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.mt.6300321","article-title":"Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide","volume":"16","author":"Kreppel","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0300","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymthe.2005.03.006","article-title":"Combined genetic and chemical capsid modifications enable flexible and efficient de- and retargeting of adenovirus vectors","volume":"12","author":"Kreppel","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0305","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1089\/hum.2009.028","article-title":"Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus","volume":"20","author":"Doronin","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0310","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2007.06.010","article-title":"Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration","volume":"122","author":"Gao","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2019.06.059_b0315","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1089\/hum.2008.091","article-title":"Effects of shielding adenoviral vectors with polyethylene glycol on vector-specific and vaccine-mediated immune responses","volume":"19","author":"Weaver","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0320","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/sj.mt.6300306","article-title":"Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies","volume":"16","author":"Wortmann","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0325","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/gt.2009.95","article-title":"Systemic administration of a PEGylated adenovirus vector with a cancer-specific promoter is effective in a mouse model of metastasis","volume":"16","author":"Yao","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0330","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/mt.2008.86","article-title":"Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression","volume":"16","author":"Hofherr","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0335","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.addr.2009.12.003","article-title":"HPMA copolymers for masking and retargeting of therapeutic viruses","volume":"62","author":"Fisher","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2019.06.059_b0340","doi-asserted-by":"crossref","first-page":"781","DOI":"10.5483\/BMBRep.2010.43.12.781","article-title":"Current advances in adenovirus nanocomplexes: more specificity and less immunogenicity","volume":"43","author":"Kang","year":"2010","journal-title":"BMB Rep."},{"key":"10.1016\/j.actbio.2019.06.059_b0345","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/sj.gt.3301389","article-title":"Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies","volume":"8","author":"Fisher","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0350","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/sj.gt.3302295","article-title":"Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus","volume":"11","author":"Green","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0355","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/10611860701501014","article-title":"Passive tumour targeting of polymer-coated adenovirus for cancer gene therapy","volume":"15","author":"Fisher","year":"2008","journal-title":"J. Drug Target."},{"key":"10.1016\/j.actbio.2019.06.059_b0360","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1517\/17425247.2014.874414","article-title":"Utilizing adenovirus vectors for gene delivery in cancer","volume":"11","author":"Kasala","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.actbio.2019.06.059_b0365","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1046\/j.1471-4159.1999.0722105.x","article-title":"Cationic lipids and polymers are able to enhance adenoviral infection of cultured mouse myotubes","volume":"72","author":"Dodds","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.actbio.2019.06.059_b0370","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1074\/jbc.272.10.6479","article-title":"Welsh, Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo","volume":"272","author":"Fasbender","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actbio.2019.06.059_b0375","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.gt.3300349","article-title":"Polycations increase the efficiency of adenovirus-mediated gene transfer to epithelial and endothelial cells in vitro","volume":"4","author":"Arcasoy","year":"1997","journal-title":"Gene Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0380","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1089\/hum.1998.9.10-1469","article-title":"Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potential","volume":"9","author":"Kaplan","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0385","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1016\/S0142-9612(02)00203-X","article-title":"Receptor-independent augmentation of adenovirus-mediated gene transfer with chitosan in vitro","volume":"23","author":"Kawamata","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.06.059_b0390","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.2967\/jnumed.112.115493","article-title":"Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene","volume":"54","author":"Gr\u00fcnwald","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.actbio.2019.06.059_b0395","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bbrc.2014.03.142","article-title":"Polyethyleneimine-coating enhances adenoviral transduction of mesenchymal stem cells","volume":"447","author":"Yao","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.actbio.2019.06.059_b0400","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jconrel.2014.06.038","article-title":"Insight into nanoparticle cellular uptake and intracellular targeting","volume":"190","author":"Yameen","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2019.06.059_b0405","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2009.11.001","article-title":"Physical adsorption of PEG grafted and blocked poly-l-lysine copolymers on adenovirus surface for enhanced gene transduction","volume":"142","author":"Park","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2019.06.059_b0410","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/jbm.a.34483","article-title":"Polyethylene glycol-grafted polyethylenimine used to enhance adenovirus gene delivery","volume":"101A","author":"Singarapu","year":"2013","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.actbio.2019.06.059_b0415","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1016\/j.biomaterials.2014.03.060","article-title":"Enhanced therapeutic efficacy of an adenovirus-PEI-bile-acid complex in tumors with low coxsackie and adenovirus receptor expression","volume":"35","author":"Lee","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.06.059_b0420","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1021\/mp9000958","article-title":"Polymer-enhanced adenoviral transduction of CAR-negative bladder cancer cells","volume":"6","author":"Kasman","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2019.06.059_b0425","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2013.12.012","article-title":"Polymer-enhanced delivery increases adenoviral gene expression in an orthotopic model of bladder cancer","volume":"176","author":"Gosnell","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2019.06.059_b0430","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1021\/acs.bioconjchem.5b00357","article-title":"Tuning surface charge and PEGylation of biocompatible polymers for efficient delivery of nucleic acid or adenoviral vector","volume":"26","author":"Choi","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.actbio.2019.06.059_b0435","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1016\/j.biomaterials.2013.03.004","article-title":"Therapeutic efficacy of a systemically delivered oncolytic adenovirus \u2013 Biodegradable polymer complex","volume":"34","author":"Kim","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.06.059_b0440","first-page":"985","article-title":"Protection of adenovirus from neutralizing antibody by cationic PEG derivative ionically linked to adenovirus","volume":"7","author":"Zeng","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2019.06.059_b0445","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1021\/acs.biomac.5b00538","article-title":"Oncolytic adenovirus coated with multidegradable bioreducible core-cross-linked polyethylenimine for cancer gene therapy","volume":"16","author":"Choi","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2019.06.059_b0450","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.biomaterials.2009.11.043","article-title":"The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy","volume":"31","author":"Kim","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.06.059_b0455","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1021\/bm501116x","article-title":"Safety profiles and antitumor efficacy of oncolytic adenovirus coated with bioreducible polymer in the treatment of a CAR negative tumor model","volume":"16","author":"Jung","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2019.06.059_b0460","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jconrel.2008.12.009","article-title":"Coating of adenovirus type 5 with polymers containing quaternary amines prevents binding to blood components","volume":"135","author":"Subr","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2019.06.059_b0465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082716","article-title":"Traceless bioresponsive shielding of adenovirus hexon with HPMA copolymers maintains transduction capacity in vitro and in vivo","volume":"9","author":"Prill","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.actbio.2019.06.059_b0470","doi-asserted-by":"crossref","first-page":"9328","DOI":"10.1016\/j.biomaterials.2011.08.066","article-title":"Bioreducible polymer-conjugated oncolytic adenovirus for hepatoma-specific therapy via systemic administration","volume":"32","author":"Kim","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.06.059_b0475","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.biomaterials.2011.11.020","article-title":"Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials","volume":"33","author":"Kim","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.06.059_b0480","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/jgm.1121","article-title":"Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer","volume":"10","author":"Green","year":"2008","journal-title":"J. Gene Med."},{"key":"10.1016\/j.actbio.2019.06.059_b0485","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/sj.mt.6300363","article-title":"Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor","volume":"16","author":"Morrison","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0490","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.tcb.2014.11.003","article-title":"Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction","volume":"25","author":"Carter","year":"2015","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.actbio.2019.06.059_b0495","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The Fibroblast Growth Factor signaling pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"key":"10.1016\/j.actbio.2019.06.059_b0500","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.semcdb.2014.01.011","article-title":"Epidermal growth factor, from gene organization to bedside","volume":"28","author":"Zeng","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.actbio.2019.06.059_b0505","first-page":"3286","article-title":"The involvement of the docking protein Gab1 in mitogenic signalling induced by EGF and HGF in rat hepatocytes","volume":"2013","author":"Aasrum","year":"1833","journal-title":"BBA-Mol. Cell Res."},{"key":"10.1016\/j.actbio.2019.06.059_b0510","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.cgt.7701022","article-title":"Incorporation of a laminin-derived peptide (SIKVAV) on polymer-modified adenovirus permits tumor-specific targeting via a6-integrins","volume":"14","author":"Stevenson","year":"2007","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0515","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/10611860400020449","article-title":"Enhanced gene transfer activity of peptide-targeted gene-delivery vectors","volume":"13","author":"Parker","year":"2008","journal-title":"J. Drug Target."},{"key":"10.1016\/j.actbio.2019.06.059_b0520","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/hum.2008.167","article-title":"Cetuximab retargeting of adenovirus via the epidermal growth factor receptor for treatment of intraperitoneal ovarian cancer","volume":"20","author":"Morrison","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0525","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3109\/1061186X.2010.547585","article-title":"E-selectin is a viable route of infection for polymer-coated adenovirus retargeting in TNF-\u03b1-activated human umbilical vein endothelial cells","volume":"19","author":"Bachtarzi","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.actbio.2019.06.059_b0530","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1007\/s11095-010-0088-8","article-title":"Multi-component polymeric system for tumour cell-specific gene delivery using a universal bungarotoxin linker","volume":"27","author":"Willemsen","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actbio.2019.06.059_b0535","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1089\/10430349950016654","article-title":"Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice","volume":"10","author":"Romanczuk","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0540","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1021\/bc700385r","article-title":"Enhancement of star vector-based gene delivery to endothelial cells by addition of RGD-peptide","volume":"19","author":"Ishikawa","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.actbio.2019.06.059_b0545","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/gt.2011.74","article-title":"Impact of polyplex micelles installed with cyclic RGD peptide as ligand on gene delivery to vascular lesions","volume":"19","author":"Kagaya","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0550","first-page":"265","article-title":"Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins","volume":"13","author":"Koivunen","year":"1995","journal-title":"Biotechnology"},{"key":"10.1016\/j.actbio.2019.06.059_b0555","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.carbpol.2017.07.035","article-title":"Targeted gene delivery of polyethyleneimine-grafted chitosan with RGD dendrimer peptide in \u03b1v\u03b23 integrin-overexpressing tumor cells","volume":"174","author":"Kim","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.actbio.2019.06.059_b0560","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/10430340460745766","article-title":"A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo","volume":"15","author":"Ogawara","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0565","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/jgm.699","article-title":"PEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion ability","volume":"7","author":"Eto","year":"2005","journal-title":"J. Gene Med."},{"key":"10.1016\/j.actbio.2019.06.059_b0570","first-page":"130","article-title":"Imaging chemically modified adenovirus for targeting tumors expressing integrin avb3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene","volume":"47","author":"Xiong","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.actbio.2019.06.059_b0575","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11307-007-0079-2","article-title":"In vivo bioluminescence tumor imaging of RGD peptide-modified adenoviral vector encoding firefly luciferase reporter gene","volume":"9","author":"Niu","year":"2007","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.actbio.2019.06.059_b0580","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1525-0016(03)00139-4","article-title":"Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates","volume":"8","author":"Lanciotti","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0585","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.bbrc.2007.12.045","article-title":"Epidermal growth factor (EGF) receptor targeted delivery of PEGylated adenovirus","volume":"366","author":"Park","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.actbio.2019.06.059_b0590","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.biomaterials.2010.10.031","article-title":"Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin","volume":"32","author":"Kim","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.06.059_b0595","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2007.08.002","article-title":"Retargeting of adenoviral gene delivery via Herceptin\u2013PEG\u2013adenovirus conjugates to breast cancer cells","volume":"123","author":"Jung","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2019.06.059_b0600","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/981389e9-e5a1-4be6-bf55-841a7102a623","article-title":"Development of adenoviral delivery systems to target hepatic stellate cells in vivo","volume":"8","author":"Reetz","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.actbio.2019.06.059_b0605","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/mt.2011.112","article-title":"Tumor vascular targeted delivery of polymer-conjugated adenovirus vector for cancer gene therapy","volume":"19","author":"Yao","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0610","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1021\/mp300366f","article-title":"Adenoviral vectors coated with PAMAM dendrimer conjugates allow CAR independent virus uptake and targeting to the EGF receptor","volume":"10","author":"Vetter","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2019.06.059_b0615","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/jgm.853","article-title":"Photochemically enhanced transduction of polymer-complexed adenovirus targeted to the epidermal growth factor receptor","volume":"8","author":"Bonsted","year":"2006","journal-title":"J. Gene Med."},{"key":"10.1016\/j.actbio.2019.06.059_b0620","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jconrel.2010.06.027","article-title":"Ionically crosslinked Ad\/chitosan nanocomplexes processed by electrospinning for targeted cancer gene therapy","volume":"148","author":"Park","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2019.06.059_b0625","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jconrel.2013.03.030","article-title":"Therapeutic targeting of chitosan\u2013PEG\u2013folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy","volume":"169","author":"Kwon","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2019.06.059_b0630","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1016\/j.biomaterials.2011.03.084","article-title":"Active targeting of RGD-conjugated bioreducible polymer for delivery of oncolytic adenovirus expressing shRNA against IL-8 mRNA","volume":"32","author":"Kim","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.06.059_b0635","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/gt.2014.18","article-title":"Efficient lung orthotopic tumor-growth suppression of oncolytic adenovirus complexed with RGD-targeted bioreducible polymer","volume":"21","author":"Kim","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0640","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.2174\/0929867311320200008","article-title":"Functional characterization of a PEI-CyD-FA-coated adenovirus as delivery vector for gene therapy","volume":"20","author":"Yao","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.actbio.2019.06.059_b0645","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature12627","article-title":"Tumour heterogeneity in the clinic","volume":"501","author":"Bedard","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2019.06.059_b0650","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2217\/nnm-2016-0060","article-title":"Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy","volume":"11","author":"Kasala","year":"2016","journal-title":"Nanomedicine-UK"},{"key":"10.1016\/j.actbio.2019.06.059_b0655","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2008.05.003","article-title":"Recent progress in tumor pH targeting nanotechnology","volume":"132","author":"Lee","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2019.06.059_b0660","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jconrel.2015.10.009","article-title":"Polymeric oncolytic adenovirus for cancer gene therapy","volume":"219","author":"Choi","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2019.06.059_b0665","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jconrel.2015.01.005","article-title":"pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis","volume":"205","author":"Choi","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2019.06.059_b0670","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.actbio.2015.09.014","article-title":"Enhanced anti-tumor efficacy and safety profile of tumor microenvironment-responsive oncolytic adenovirus nanocomplex by systemic administration","volume":"28","author":"Choi","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2019.06.059_b0675","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.biomaterials.2014.11.021","article-title":"Dual tumor targeting with pH-sensitive and bioreducible polymer-complexed oncolytic adenovirus","volume":"41","author":"Moon","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.06.059_b0680","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1073\/pnas.0910283107","article-title":"Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases","volume":"107","author":"Olson","year":"2010","journal-title":"Proc. Natl. Acad Sci."},{"key":"10.1016\/j.actbio.2019.06.059_b0685","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1073\/pnas.0910261107","article-title":"Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival","volume":"107","author":"Nguyen","year":"2010","journal-title":"Proc. Natl. Acad Sci."},{"key":"10.1016\/j.actbio.2019.06.059_b0690","article-title":"The targeted transduction of MMP-overexpressing tumor cells by ACPP-HPMA copolymer-coated adenovirus conjugates","volume":"9","author":"Li","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.actbio.2019.06.059_b0695","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.actbio.2015.11.005","article-title":"Bio-inspired polymer envelopes around adenoviral vectors to reduce immunogenicity and improve in vivo kinetics","volume":"30","author":"Fan","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2019.06.059_b0700","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3390\/v8120337","article-title":"Insights into adenovirus uncoating from interactions with integrins and mediators of host immunity","volume":"8","author":"Nemerow","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.actbio.2019.06.059_b0705","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/sj.mt.6300326","article-title":"Breaking the bonds: non-viral vectors become chemically dynamic","volume":"16","author":"Wolff","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2019.06.059_b0710","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.33549\/physiolres.933139","article-title":"Nanotherapeutics shielded with a pH responsive polymeric layer","volume":"64","author":"Kostka","year":"2015","journal-title":"Physiol. Res."},{"key":"10.1016\/j.actbio.2019.06.059_b0715","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3390\/v2020468","article-title":"PEGylated adenoviruses: from mice to monkeys","volume":"2","author":"Wonganan","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.actbio.2019.06.059_b0720","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1517\/17425247.5.4.385","article-title":"Polymers for viral gene delivery","volume":"5","author":"Wang","year":"2008","journal-title":"Expert Opin. Drug Deliev."},{"key":"10.1016\/j.actbio.2019.06.059_b0725","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1089\/hum.2009.171","article-title":"Capsomer-specific fluorescent labeling of adenoviral vector particles allows for detailed analysis of intracellular particle trafficking and the performance of bioresponsive bonds for vector capsid modifications","volume":"21","author":"Espenlaub","year":"2010","journal-title":"Hum. Gene Ther."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706119305471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706119305471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:23:31Z","timestamp":1761672211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706119305471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":145,"alternative-id":["S1742706119305471"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2019.06.059","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the functions of polymers in adenovirus-mediated gene delivery: Evading immune response and redirecting tropism","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2019.06.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}